Jay Edward Birnbaum's most recent trade in Sonoma Pharmaceuticals Inc. was a trade of 7,500 Stock option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc. | Jay Edward Birnbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,500 | 10,029 | - | - | Stock option (right to buy) |